MedTrace Logo

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

NCT06688175 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-08-07

No results posted yet for this study

Summary

This prospective, multicenter, single-arm, open-label phase II clinical study aimed to investigate the efficacy and safety of intensity-modulated radiotherapy combined with lobaplatin-based concurrent chemotherapy in the treatment of elderly patients with nasopharyngeal carcinoma

Conditions

  • Nasopharyngeal Neoplasms
  • Elderly
  • Chemotherapy

Interventions

DRUG

IMRT combined with lobaplatin-based concurrent chemotherapy

IMRT combined with two cycles of lobaplatin-based concurrent chemotherapy

Sponsors & Collaborators

  • The First Affiliated Hospital of Xiamen University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-13
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06688175 on ClinicalTrials.gov